Prognostic value of three-dimensional echocardiographic right ventricular ejection fraction in patients with pulmonary arterial hypertension

Mitsushige Murata, Toshimitsu Tsugu, Takashi Kawakami, Masaharu Kataoka, Yugo Minakata, Jin Endo, Hikaru Tsuruta, Yuji Itabashi, Yuichiro Maekawa, Mitsuru Murata, Keiichi Fukuda

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Right ventricular (RV) function is an independent predictor of clinical outcomes in patients with pulmonary arterial hypertension (PAH). However, it remains controversial which RV parameter should be measured as an appropriate index for the treatment of PAH. The aim of this study was to identify the most useful parameter that correlates with hemodynamics and predicts clinical outcomes in PAH. Results: Most of the clinical and echocardiographic RV parameters were significantly correlated with pulmonary vascular resistance (PVR) as well as mean pulmonary arterial pressure (mPAP). Among these, three dimensional right ventricular ejection fraction (3DRVEF) showed the strongest hemodynamic correlation, followed by 6-minute walk distance. Receiver operating characteristic analysis of association with cardiac events including death, hospitalization, and intervention revealed a greater area under the curve for 3DRVEF than for mPAP (0.78 vs. 0.74). Kaplan- Meier analysis showed that patients with 3DRVEF less than 38% had significantly shorter event-free survival than those with greater than 38% (P = 0.0007). Finally, the Cox proportional hazards analysis revealed that 3DRVEF, but not mPAP, was an independent predictor of clinical events in PAH. Materials and Methods: Eighty-six consecutive patients were enrolled in this study. RV hemodynamic parameters were measured by right heart catheterization (RHC). RV function was assessed using two-dimensional speckle-tracking echocardiography and three-dimensional transthoracic echocardiography (3DTTE) to evaluate RV free wall global strain (RVFS) and RVEF. Conclusions: RVEF measured by 3DTTE could be a useful parameter for noninvasively assessing RV hemodynamics and predicting the clinical outcomes in PAH patients.

Original languageEnglish
Pages (from-to)86781-86790
Number of pages10
JournalOncotarget
Volume7
Issue number52
DOIs
Publication statusPublished - 2016

Fingerprint

Pulmonary Hypertension
Stroke Volume
Hemodynamics
Right Ventricular Function
Arterial Pressure
Lung
Three-Dimensional Echocardiography
Kaplan-Meier Estimate
Cardiac Catheterization
ROC Curve
Vascular Resistance
Disease-Free Survival
Area Under Curve
Echocardiography
Hospitalization
Therapeutics

Keywords

  • Prognosis
  • Pulmonary arterial hypertension
  • Right ventricular ejection fraction
  • Right ventricular function
  • Three-dimensional echocardiography

ASJC Scopus subject areas

  • Oncology

Cite this

Prognostic value of three-dimensional echocardiographic right ventricular ejection fraction in patients with pulmonary arterial hypertension. / Murata, Mitsushige; Tsugu, Toshimitsu; Kawakami, Takashi; Kataoka, Masaharu; Minakata, Yugo; Endo, Jin; Tsuruta, Hikaru; Itabashi, Yuji; Maekawa, Yuichiro; Murata, Mitsuru; Fukuda, Keiichi.

In: Oncotarget, Vol. 7, No. 52, 2016, p. 86781-86790.

Research output: Contribution to journalArticle

Murata, Mitsushige ; Tsugu, Toshimitsu ; Kawakami, Takashi ; Kataoka, Masaharu ; Minakata, Yugo ; Endo, Jin ; Tsuruta, Hikaru ; Itabashi, Yuji ; Maekawa, Yuichiro ; Murata, Mitsuru ; Fukuda, Keiichi. / Prognostic value of three-dimensional echocardiographic right ventricular ejection fraction in patients with pulmonary arterial hypertension. In: Oncotarget. 2016 ; Vol. 7, No. 52. pp. 86781-86790.
@article{66b1bc0eef4a45f4bbbdcbd551bff158,
title = "Prognostic value of three-dimensional echocardiographic right ventricular ejection fraction in patients with pulmonary arterial hypertension",
abstract = "Background: Right ventricular (RV) function is an independent predictor of clinical outcomes in patients with pulmonary arterial hypertension (PAH). However, it remains controversial which RV parameter should be measured as an appropriate index for the treatment of PAH. The aim of this study was to identify the most useful parameter that correlates with hemodynamics and predicts clinical outcomes in PAH. Results: Most of the clinical and echocardiographic RV parameters were significantly correlated with pulmonary vascular resistance (PVR) as well as mean pulmonary arterial pressure (mPAP). Among these, three dimensional right ventricular ejection fraction (3DRVEF) showed the strongest hemodynamic correlation, followed by 6-minute walk distance. Receiver operating characteristic analysis of association with cardiac events including death, hospitalization, and intervention revealed a greater area under the curve for 3DRVEF than for mPAP (0.78 vs. 0.74). Kaplan- Meier analysis showed that patients with 3DRVEF less than 38{\%} had significantly shorter event-free survival than those with greater than 38{\%} (P = 0.0007). Finally, the Cox proportional hazards analysis revealed that 3DRVEF, but not mPAP, was an independent predictor of clinical events in PAH. Materials and Methods: Eighty-six consecutive patients were enrolled in this study. RV hemodynamic parameters were measured by right heart catheterization (RHC). RV function was assessed using two-dimensional speckle-tracking echocardiography and three-dimensional transthoracic echocardiography (3DTTE) to evaluate RV free wall global strain (RVFS) and RVEF. Conclusions: RVEF measured by 3DTTE could be a useful parameter for noninvasively assessing RV hemodynamics and predicting the clinical outcomes in PAH patients.",
keywords = "Prognosis, Pulmonary arterial hypertension, Right ventricular ejection fraction, Right ventricular function, Three-dimensional echocardiography",
author = "Mitsushige Murata and Toshimitsu Tsugu and Takashi Kawakami and Masaharu Kataoka and Yugo Minakata and Jin Endo and Hikaru Tsuruta and Yuji Itabashi and Yuichiro Maekawa and Mitsuru Murata and Keiichi Fukuda",
year = "2016",
doi = "10.18632/oncotarget.13505",
language = "English",
volume = "7",
pages = "86781--86790",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "52",

}

TY - JOUR

T1 - Prognostic value of three-dimensional echocardiographic right ventricular ejection fraction in patients with pulmonary arterial hypertension

AU - Murata, Mitsushige

AU - Tsugu, Toshimitsu

AU - Kawakami, Takashi

AU - Kataoka, Masaharu

AU - Minakata, Yugo

AU - Endo, Jin

AU - Tsuruta, Hikaru

AU - Itabashi, Yuji

AU - Maekawa, Yuichiro

AU - Murata, Mitsuru

AU - Fukuda, Keiichi

PY - 2016

Y1 - 2016

N2 - Background: Right ventricular (RV) function is an independent predictor of clinical outcomes in patients with pulmonary arterial hypertension (PAH). However, it remains controversial which RV parameter should be measured as an appropriate index for the treatment of PAH. The aim of this study was to identify the most useful parameter that correlates with hemodynamics and predicts clinical outcomes in PAH. Results: Most of the clinical and echocardiographic RV parameters were significantly correlated with pulmonary vascular resistance (PVR) as well as mean pulmonary arterial pressure (mPAP). Among these, three dimensional right ventricular ejection fraction (3DRVEF) showed the strongest hemodynamic correlation, followed by 6-minute walk distance. Receiver operating characteristic analysis of association with cardiac events including death, hospitalization, and intervention revealed a greater area under the curve for 3DRVEF than for mPAP (0.78 vs. 0.74). Kaplan- Meier analysis showed that patients with 3DRVEF less than 38% had significantly shorter event-free survival than those with greater than 38% (P = 0.0007). Finally, the Cox proportional hazards analysis revealed that 3DRVEF, but not mPAP, was an independent predictor of clinical events in PAH. Materials and Methods: Eighty-six consecutive patients were enrolled in this study. RV hemodynamic parameters were measured by right heart catheterization (RHC). RV function was assessed using two-dimensional speckle-tracking echocardiography and three-dimensional transthoracic echocardiography (3DTTE) to evaluate RV free wall global strain (RVFS) and RVEF. Conclusions: RVEF measured by 3DTTE could be a useful parameter for noninvasively assessing RV hemodynamics and predicting the clinical outcomes in PAH patients.

AB - Background: Right ventricular (RV) function is an independent predictor of clinical outcomes in patients with pulmonary arterial hypertension (PAH). However, it remains controversial which RV parameter should be measured as an appropriate index for the treatment of PAH. The aim of this study was to identify the most useful parameter that correlates with hemodynamics and predicts clinical outcomes in PAH. Results: Most of the clinical and echocardiographic RV parameters were significantly correlated with pulmonary vascular resistance (PVR) as well as mean pulmonary arterial pressure (mPAP). Among these, three dimensional right ventricular ejection fraction (3DRVEF) showed the strongest hemodynamic correlation, followed by 6-minute walk distance. Receiver operating characteristic analysis of association with cardiac events including death, hospitalization, and intervention revealed a greater area under the curve for 3DRVEF than for mPAP (0.78 vs. 0.74). Kaplan- Meier analysis showed that patients with 3DRVEF less than 38% had significantly shorter event-free survival than those with greater than 38% (P = 0.0007). Finally, the Cox proportional hazards analysis revealed that 3DRVEF, but not mPAP, was an independent predictor of clinical events in PAH. Materials and Methods: Eighty-six consecutive patients were enrolled in this study. RV hemodynamic parameters were measured by right heart catheterization (RHC). RV function was assessed using two-dimensional speckle-tracking echocardiography and three-dimensional transthoracic echocardiography (3DTTE) to evaluate RV free wall global strain (RVFS) and RVEF. Conclusions: RVEF measured by 3DTTE could be a useful parameter for noninvasively assessing RV hemodynamics and predicting the clinical outcomes in PAH patients.

KW - Prognosis

KW - Pulmonary arterial hypertension

KW - Right ventricular ejection fraction

KW - Right ventricular function

KW - Three-dimensional echocardiography

UR - http://www.scopus.com/inward/record.url?scp=85007497574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007497574&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.13505

DO - 10.18632/oncotarget.13505

M3 - Article

C2 - 27893420

AN - SCOPUS:85007497574

VL - 7

SP - 86781

EP - 86790

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 52

ER -